One-day Essentials Contraception. Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire
|
|
- Shanon Cameron
- 5 years ago
- Views:
Transcription
1 One-day Essentials Contraception { Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire
2 80% women access contraception from their GP Therefore it is essential that primary care providers are up to date and can offer choice from the contraceptive menu, based on an individual assessment..
3 Angie needs EC Too busy to get to the doctors - ran out of pills about 1-2 weeks ago!! UPSI 3 or 4 days ago (can t be sure) 6 children Recently gave birth to twins and could not cope with another pregnancy now
4 If problems with contraception, when is EC needed? 2 or more COC missed in first week (changed missed pill rules in 2011) >3 h late POP (12h for Cerazette) IUD/IUS expelled/removed Injection >2/52 late Condom non perfect use Interacting drugs
5 FSRH Guidance 2012 Emergency Contraception Risk of ovulation 10 days after last COC CEU EC Guidance, Revised Jan 2012
6 When in the cycle is the risk highest? Max risk
7 Asking for Levonelle Had Levonelle recently No adverse effects same again please? OR Can you do better?
8 Management of a request for Emergency Contraception What do you need to know? Consider possibility of an implanted pregnancy Timing of episode(s) of UPSI? LMP or withdrawal bleed? Potential drug interactions? Medical eligibility? Explain all method options Discuss on-going contraception Discuss STIs Arrange any necessary referral/follow-up
9 CEU Emergency Contraception Guidance January /05/2012
10 Available options CHOICE Copper IUD Ulipristal Acetate (UPA) Levonorgestrel (LNG)
11 Copper IUD mode of action Emergency IUD can be fitted within 5 days of UPSI or within 5 days of earliest calculated day of ovulation If she is amenable to an IUD, is it available as an option and if not, are pathways/communication processes in place to ensure that this option can be made available to her from an alternative provider
12 Levonorgestrel (LNG)
13 Ulipristal acetate (UPA)
14 UPA - Mode of Action Primary mode of action is to inhibit or delay ovulation The probability of conception peaks just before ovulation ellaone s inhibitory effect on follicular rupture allows it to be effective in some women even when administered immediately before ovulation, even if LH levels have already begun to rise CEU EC Guidance, Revised Jan 2012
15 Effectiveness of oral EC Inhibition of follicular rupture (>18mm) at 5 days after treatment Levonorgestrel 7/ % Ulipristal Acetate 20/ % p< Does not give any protection later in cycle and may just delay ovulation Brache et al 2010
16 When in the cycle is EC effective? Ulipristal Max risk LNG IUD
17 Efficacy related to mode of action Pills delay/inhibit ovulation UPA > LNG No evidence of effect after fertilisation LNG no effect after ovulation UPA no evidence of effect after ovulation IUD may prevent fertilisation IUD inhibits implantation CEU EC Guidance, Revised Jan 2012
18 Emergency Contraception Effectiveness If 1000 women had UPSI and used. Cu IUD, ellaone, LNG, Nothing James Trussell 2011
19 Adverse events Oral (LNG, UPA) Nausea (slight) Vomiting (rare 2-3h) Some delay to cycle IUD Insertion related (discomfort/pain; infection if at risk of STI; expulsion/perforation) Heavy menstrual bleeding if long term use CEU EC Guidance, Revised Jan 2012
20 Drug Interactions UPA and Levonorgestrel concomitant use of: Liver enzyme inducers UPA Medications that raise gastric ph proton pump inhibitors, H2-receptor antagonists, antacids Levonorgestrel containing emergency contraception - discuss CEU EC Guidance, Revised Jan 2012 Summary of Product Characteristics (UPA). Revised Nov 2011
21 Contraindications & Precautions to UPA Pregnancy Hypersensitivity Asthma insufficiently controlled with oral steroids Severe hepatic or renal impairment Rare hereditary disorders: Galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption Summary of Product Characteristics. Revised Nov 2011
22
23 {
24 CEU Quick Starting Guidance September 2010 Emergency contraception alone is not enough 24 16/05/2012
25 Then what? Quick start can she have? CHC: COC? Evra? NuvaRing? POP? Nexplanon? DMPA? IUS?
26 Contraceptive use among women aged in England and Wales (2007) OC (COC or POP) 28% Male condom 24% Sterilised / partner sterilised 17% IUD 4% Injection / implant 5% IUS 3% Cap / diaphragm 0% Periodic abstinence (rhythm) 2% Contraception and Sexual Health Office for National Statistics
27 Accidental pregnancy in first year of use typical use Perfect use Typical use percent Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J et al. Contraceptive Technology, revised edition 19. NY: Ardent Media, 2007
28 FSRH CHC guidance
29 UKMEC
30 Sub-dermal implant Failure rate <0.1% at 3 years Regular follow-up not required Position of implant important for removal Counselling important for compliance
31 Depo Provera(DMPA) 150mg Depo Medroxyprogesterone Acetate Injection given i.m. every 12 weeks ( licence 12+5 days) now up to 14 weeks <4/1000 failure rate Inhibits ovulation
32 Drug interactions
33 Guidance on antibiotics and contraceptive pill interaction changed GPs have been given the goahead to prescribe almost all classes of antibiotics to women who take the contraceptive pill, in a major change to current practice prompted by new evidence on the interactions between the drugs.
34 NICE - Key Priorities for Implementation Women requiring contraception should be given information about and offered a choice of all methods, including LARCs. All IUD/IUS/depo/implant are more cost effective than the COC even at 1 year of use IUD/IUS/implants are more cost effective than depo - provera Increasing the uptake of LARCs will reduce the numbers of unintended pregnancies.
35 LARCS Depo Provera Implanon Cu IUD copper coil Mirena IUS hormone coil
36 Mirena EvoInserter advantages compared to original inserter 3 Simplified loading by pushing the slider forwards to its furthest position 2 Mirena is already in the horizontal position 1 Threads are inside the inserter handle 6 Smaller diameter insertion tube 4 More ergonomic shape of slider and handle 5 Double-sided centimetre scale
37 Improving compliance Offering choices Right product, right time Managing expectations Counselling re side effects Managing adverse effects
38 Useful websites Clinical Effectiveness Unit of the Faculty of Sexual and Reproductive Health Emergency contraception (January 2012) Quick Start, Missed pills, drug interactions All reversible methods, particular situations, FAQs Medical Eligibility Criteria for contraceptive use Selected practice recommendations for contraceptive use e-diploma from January 2010 all with NHS address via patient leaflets and information
MMPr001 EMERGENCY CONTRACEPTION PROTOCOL
MMPr001 EMERGENCY CONTRACEPTION PROTOCOL Table of Contents MMPr001 EMERGENCY CONTRACEPTION PROTOCOL... 1 Why we need this Protocol... 2 What the Protocol is trying to do... 2 Which stakeholders have been
More informationManagement of Emergency Contraception (EC)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Management of Emergency Contraception (EC) The risks and benefits of an IUD or oral EC should be discussed and documented (see appendix). Reasonable measures
More informationMMPr001 EMERGENCY CONTRACEPTION PROTOCOL
MMPr001 EMERGENCY CONTRACEPTION PROTOCOL MMPr001 Emergency Contraception - (Sept18-Sept20) Page 1 of 8 Table of Contents MMPr001 EMERGENCY CONTRACEPTION PROTOCOL... 1 Why we need this protocol... 3 What
More informationContraception for Adolescents: What s New?
Contraception for Adolescents: What s New? US Medical Eligibility Criteria for Contraceptive Use Kathryn M. Curtis, PhD Division of Reproductive Health, CDC Expanding Our Experience and Expertise: Implementing
More informationContraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016
Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Disclosure I am a Nexplanon trainer for Merck. Objectives Understand how obesity may affect pharmacokinetics
More informationContraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE
Contraception Choices: An Evidence Based Approach Case Study Approach Susan Hellier PhD, DNP, FNP-BC, CNE Objectives Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC)
More informationIncreasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland
Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland Dr Audrey Brown Dr Alison Bigrigg Greater Glasgow and Clyde Long-acting reversible
More informationMedical Eligibility for Contraception Use
Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist
More informationCLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR EMERGENCY HORMONAL CONTRACEPTION Levonorgestrel 1500mcg
CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR EMERGENCY HORMONAL CONTRACEPTION Levonorgestrel 1500mcg Version Control This document is only valid on the day it was printed The current version of this
More informationEmergency Contraception THE FACTS
Emergency Contraception Quick Facts What is it? Emergency contraception is birth control that you use after you have had unprotected sex--if you didn t use birth control or your regular birth control failed.
More informationEmergency Contracep/on & Post Exposure Prophylaxis. Dr Catherine White FMERSA 19 th January 2016
Emergency Contracep/on & Post Exposure Prophylaxis Dr Catherine White FMERSA 19 th January 2016 There are two main methods of emergency contracep/on (E.C) Hormonal (Morning amer pill) Levonorgestrel (LNG)
More informationPatient Group Direction for LEVONELLE (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationthe IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to
your guide to Helping you choose the method of contraception that s best for you IUD IUD the e IUD IU IUD the IUD 2 3 The intrauterine device (IUD) An IUD is a small plastic and copper device that s put
More informationPATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OR ADMINISTRATION OF LEVONORGESTREL 1500 MICROGRAM TABLET (e.g LEVONELLE 1500 ) PGD
This Patient Group Direction () must only be used by registered pharmacists who have been named and authorized by their organization to practice under it. The most recent and in date final signed version
More informationInternational Federation of Gynecology and Obstetrics
International Federation of Gynecology and Obstetrics THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION
More informationLevonorgestrel 1500 micrograms by Community Pharmacists
Patient Group Direction for the supply/administration of by Community Pharmacists Valid from 1st August 2015 to 31st July 2017* This patient group direction must be agreed to and signed by all pharmacists
More informationContraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital
Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception
More informationContraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine
Contraception Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Disclosures No financial relationships to disclose I have no commercial, financial, research ties to
More informationFIGO and Prevention of Unsafe Abortion LARC and PM for PAC
FIGO and Prevention of Unsafe Abortion LARC and PM for PAC Dr. Anibal Faundes Second Regional Francophone West Africa PAC Meeting: Strengthening Postabortion Family Planning Saly, Senegal, October 6-11,
More informationContraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare
Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare Declaration of Competing Interests I have not received
More informationPatient Group Direction for the administration of Levonorgestrel Emergency Contraception for Community Pharmacy
Patient Group Direction for the administration of Levonorgestrel for Community Pharmacy Author Corporate Lead Chris Toothill (Medicines Management Pharmacist, Governance and Risk, Leeds Community Healthcare
More informationUpdate on EC methods and mechanism of action. Emergency Contraception (EC) Historical EC (1) Historical EC (2) Current EC Options
ESC Meeting 2016 Update on EC methods and mechanism of action Dr. Raymond Li MBBS, MMedSC, FRCOG, FHKAM (O&G) Cert RCOG/HKCOG (Reprod Med) Department of O&G, The University of Hong Kong The Family Planning
More informationGlobal Contraception
Video Companion Guide Global Contraception Learning Objectives: By the end of the session, learners will be able to: Describe of all contraceptive methods. Develop a basic understanding of patient-centered
More informationWHAT ARE CONTRACEPTIVES?
CONTRACEPTION WHAT ARE CONTRACEPTIVES? Methods used to prevent fertilization *Also referred to as birth control methods With contraceptives, it is important to look at what works for you and your body.
More informationLinda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit
Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit What We Plan To Do Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC) Explain
More informationLEVONORGESTREL 1500 microgram tablets
Patient Group Direction for the supply of LEVONORGESTREL 1500 microgram tablets by Community Pharmacists Valid from: July 1 st 2014 Review: June 30 th 2015 Expiry date: June 30 th 2016 PGD Reference Number:
More informationLONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables
LONG-ACTING REVERSIBLE CONTRACEPTION Summary Tables Bridging the Divide: A Project of the Jacobs Institute of Women s Health June 2016 Table 1. Summary of LARC Methods Available Years Since Effective Copper
More informationLARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures
LARC: Long Acting Reversible Contraception Disclosures I have no relevant financial disclosures Jennifer Kerns, MD, MPH Assistant Professor, UCSF Obstetrics, Gynecology and Reproductive Sciences San Francisco
More informationContraceptive case studies. Dr Christine Roke National Medical Advisor Family Planning June 2015
Contraceptive case studies Dr Christine Roke National Medical Advisor Family Planning June 2015 Case 1 Mary is a 47 year old who has come in for a routine cervical smear. She asks when her Multiload IUD
More informationEmergency contraception methods, including oral and
FOCUS Emergency contraception: Oral and intrauterine options Kirsten I Black, Safeera Y Hussainy Background Emergency contraception can be used to prevent pregnancy where contraception has not been used,
More informationPatient Group Direction For the administration of Levonorgestrel 1500micrograms by Pharmacists, for Emergency Hormonal Contraception
Patient Group Direction For the administration of Levonorgestrel 1500micrograms by Pharmacists, for Emergency Hormonal Contraception This Patient Group Direction has been adapted for use by NHS Tayside
More informationUnintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use
3:45 4:30 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial
More informationLEVONORGESTREL 1500 microgram Tablet (e.g. LEVONELLE )
PATIENT GROUP DIRECTION (PGD) FOR PGD 219 (COMMUNITY PHARMACIES) LEVONORGESTREL 1500 microgram Tablet (e.g. LEVONELLE ) POM YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE
More informationClinical Guidance: Drug Interactions with Hormonal Contraception
Clinical Guidance: Drug Interactions with Hormonal Contraception January 2018 FSRH Copyright Faculty of Sexual & Reproductive Healthcare January 2018 1 Drug Interactions with Hormonal Contraception Purpose
More informationlevonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer
levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises
More informationGuidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception
Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception Pharmaceutical Society of Ireland Version 4 December 2016 Updates made following
More informationLong Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator
Publication Report Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator Year ending March 2014 Publication date 30 September 2014 A National Statistics Publication for Scotland
More informationBEST PRACTICES IN CONTRACEPTIVE COUNSELING
Condition Sub-condition Combined pill, patch, ring Anemias a) Thalassemia 1 1 1 1 1 2 b) Sickle cell disease 2 1 1 1 1 2 c) Iron-deficiency anemia 1 1 1 1 1 2 Benign ovarian (including cysts) 1 1 1 1 1
More informationLEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common
4:15 5 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial
More informationLong Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator
Publication Report Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator Year ending March 2012 Publication date 25 September 2012 A National Statistics Publication for Scotland
More informationContraceptives. Kim Dawson October 2010
Contraceptives Kim Dawson October 2010 Objectives: You will learn about: The about the different methods of birth control. How to use each method of birth control. Emergency contraception What are they?
More informationPatient Group Direction For the administration of Levonorgestrel 1500micrograms by Pharmacists, for Emergency Hormonal Contraception
Patient Group Direction For the administration of Levonorgestrel 1500micrograms by Pharmacists, for Emergency Hormonal Contraception PGD Review Date: December 2017-1 - 1. Authorisation This specimen Patient
More informationDoes use of emergency contraception prevent unintended pregnancy? Anna Glasier
Does use of emergency contraception prevent unintended pregnancy? Anna Glasier There has never been a placebo controlled trial of emergency contraception So to assess whether EC works we have to look to
More informationUNCONTROLLED WHEN PRINTED
National Patient Group Direction for the Supply of Levonorgestrel 1500mcg tablet (Levonelle 1500), by Pharmacists, for Emergency Hormonal Contraception UNCONTROLLED WHEN PRINTED EFFECTIVE FROM OCTOBER
More informationThe Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH
The Doctor Is In Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH Contraception Resources from the CDC: 2016 U.S. Medical Eligibility Criteria
More informationSexual health: Hot topics. Anne Connolly Vice President FSRH
Sexual health: Hot topics Anne Connolly Vice President FSRH To cover Contraception choices Contraception safety Sexual history taking Relevant tests We don t do great. 30 50% pregnancies are unplanned
More informationLong Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator
Publication Report Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator Year ending March 2013 Publication date 24 September 2013 A National Statistics Publication for Scotland
More information1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during : A systematic analysis
1 2 3 1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980 2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet
More informationEmergency contraception is an occasional method. It should in no instance replace a regular contraceptive method.
1. NAME OF THE MEDICINAL PRODUCT: Levonorgestrel Tablets 1.5 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION: Each tablet contains levonorgestrel 1.5 mg. Excipient with known effect: Each tablet contains
More informationLong Acting Reversible Methods of Contraception (LARC) in Scotland
Publication Report Long Acting Reversible Methods of Contraception (LARC) in Scotland Year ending March 2015 Publication date 3 November 2015 A National Statistics Publication for Scotland Contents Introduction...
More informationThrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor
Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service
More informationThe following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that
The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that may be used in the future Abstinence Choosing not to
More informationPatient Group Direction For The Supply Of Levonorgestrel For Emergency Hormonal Contraception By Pharmacists Working Within NHS Grampian
Patient Group Direction For The Supply Of Levonorgestrel For Emergency Hormonal Contraception By Pharmacists Working Within NHS Grampian Co-ordinators: Principal Pharmacist, Pharmacy and Medicines Directorate
More informationBirth Control- an Overview. Keith Merritt, MD. Remember, all methods of birth control are safer and have fewer side effects than pregnancy
Birth Control- an Overview Keith Merritt, MD Basics Remember, all methods of birth control are safer and have fewer side effects than pregnancy Even with perfect use, each method of birth control has a
More information100% Highly effective No cost No side effects
effective? Advantages Disadvantages How do I get Cost Abstinence For some it can mean no sexual contact. For others it is no sexual intercourse or vaginal penetration. A permanent surgical procedure available
More informationOral Contraceptives. Mike Williams GPST2
Oral Contraceptives Mike Williams GPST2 Curriculum Mechanism Efficacy Advantages/Disadvantages Starting Continuing Problems/complications Contraception: effectiveness rates, risks, benefits and appropriate
More informationNHS Lothian Patient Group Direction Version: 007. Title: Levonorgestrel 1500mcg for Emergency Contraception
PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF LEVORGESTREL 1500mcg FOR EMERGENCY CONTRACEPTION BY DESIGNATED HEALTHCARE PROFESSIONALS PROVIDING SEXUAL HEALTH SERVICES, UNSCHEDULED CARE SERVICES OR
More informationTime Topic Speaker Abbreviation
1. Programme Sunday, 4 th November 2018 Time Topic Speaker Abbreviation 08:00 Welcome, distribution materials 08:30 Overview of the Medical Eligibility Criteria (2015), and the Selected Practices Recommendations
More informationInstruction for the patient
WS 4 Case 3 STI and IUD Your situation Instruction for the patient You are 32 years old, divorced and have one child; you have just started a new relationship You underwent surgical resection of the left
More informationDisclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck
ADOLESCENT CONTRACEPTION UPDATE APRIL 28, 2017 Brandy Mitchell, MN, RN, ANP BC, WHNP BC University of Iowa Hospitals and Clinics Obstetrics and Gynecology Iowa Association of Nurse Practitioners Spring
More informationAdolescent Hot Topics: Contraception
Adolescent Hot Topics: Contraception Dr. Stephanie Addison Holt Adolescent Medicine Objectives Discuss way to counsel the sexually active adolescent Explore the latest recommendations and updates regarding
More informationContraception and Kidney Problems: Advice for Young Adults
Contraception and Kidney Problems: Advice for Young Adults Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationSimplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok
Simplifying Vide Contraception University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Background Objectives At the conclusion of this presentation participants will be able
More informationPUBLIC HEALTH LOCAL SERVICES AGREEMENTS 2016/17 SERVICE SPECIFICATION SIGN-UP. GP Practice Subdermal Contraceptive Implants
PUBLIC HEALTH LOCAL SERVICES AGREEMENTS 2016/17 SERVICE SPECIFICATION SIGN-UP GP Practice Subdermal Contraceptive Implants Contract expiry date: 31 March 2017 Specific Training/Accreditation: Evidence
More informationBMI and Contraception: What s the Evidence?
BMI and Contraception: What s the Evidence? Kathryn M. Curtis, PhD Division of Reproductive Health Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion
More informationfemale steri e sterilisation female sterilisation male and female sterilisation male sterilisation emale sterilisation female male sterilisati
your guide to male and female sterilisation Helping you choose the method of contraception that is best for you female sterilisati le sterilisation male sterilisation e sterilisation female female ster
More informationSELECTED PRACTICE RECOMMENDATIONS FOR CONTRACEPTIVE USE
SELECTED PRACTICE RECOMMENDATIONS FOR CONTRACEPTIVE USE Second edition, 2004 COCs ECPs CICs POPs DMPA NET-EN NOR Cu-IUDs LNG-IUD NFP COCs ECPs Emergency contraception COCs POPs NFP male sterilization COCs
More informationNew Zealand Datasheet
New Zealand Datasheet 1 PRODUCT NAME POSTINOR-1 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Levonorgestrel 1.5 mg 3 PHARMACEUTICAL FORM Each round white tablet contains 1.5 mg of levonorgestrel. The tablet
More informationSame-Day Access to Highly Effective Reversible Contraception: Moving from Plan B to Happily Ever After
Same-Day Access to Highly Effective Reversible Contraception: Moving from Plan B to Happily Ever After Eleanor Bimla Schwarz, MD, MS Director, Women s Health Services Research Unit Center for Research
More informationPerimenopausal contraception: A practice-based approach
FOCUS Perimenopausal contraception: A practice-based approach Deborah Bateson, Kathleen McNamee Background Women who are perimenopausal are at risk of unintended pregnancy despite relatively low fertility
More informationBLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018
BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018 Introduction Bleeding with contraception may lead to discontinuation and possible unintended pregnancy What
More informationTable I. Examples of Hormone and Tapering Regimens
Table I. Examples of Hormone and Tapering Regimens Severe AUB Heavy bleeding (soaking through 2 maxi pads an hour, 2 hours in a row) History of heavy menses Hemodynamically un (tachycardia, hypotensive,
More informationLong-Acting Reversible Contraception: The Contraceptive CHOICE Project
Long-Acting Reversible Contraception: The Contraceptive CHOICE Project Jeffrey F. Peipert, M.D., Ph.D. Vice Chair of Clinical Research Robert J. Terry Professor Department of Obstetrics & Gynecology Washington
More informationCONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK
CONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK Global figures Women account for 51.6% of HIV globally (15.9m of 30.8m HIV+ adults) UNAIDS report on the global AIDS epidemic, 2010 Estimated no.
More informationExpanding Access to Birth Control: Will Women Get the Care They Need?
Expanding Access to Birth Control: Will Women Get the Care They Need? Target Audience: Pharmacists ACPE#: 0202-0000-18-045-L01-P Activity Type: Application-based Target Audience: ACPE#: Activity Type:
More informationSterilisation for women at the RD&E: what you need to know Reference Number: CW
Sterilisation for women at the RD&E: what you need to know Royal Devon and Exeter NHS Foundation Trust Patient Information Sterilisation for Women at The Royal Devon and Exeter Hospital What you need to
More informationWomen & Children's Business Unit Maternity Contraception and Sexual Health
Women & Children's Business Unit Maternity Contraception and Sexual Health Author/s Contact name Approval process Obstetric Guidelines Group/Associate Medical Director First Issue Date Trust intranet ref:
More informationTaking provera with nexplanon
Taking provera with nexplanon The Borg System is 100 % Taking provera with nexplanon Aug 31, 2015. Side effects for everyone are different, and the amount of time that it takes for your body to get used
More informationInformation on the risks of Valproate (Epilim) use in girls (of any age), women of childbearing potential and pregnant women.
CONTAINS NEW INFORMATION GUIDE FOR HEALTHCARE PROFESSIONALS Information on the risks of Valproate (Epilim) use in girls (of any age), women of childbearing potential and pregnant women. Read this booklet
More informationMedical Management of Fibroids Esmya. Dr Paula Briggs Consultant in Sexual and Reproductive Health
Medical Management of Fibroids Esmya Dr Paula Briggs Consultant in Sexual and Reproductive Health Treatment options for Uterine Fibroids ESMYA Selective Uterine Artery Embolisation Fibroid ablation (hysteroscopic
More informationPUBLIC HEALTH COMMUNINTY BASED SERVICES SERVICE SPECIFICATIONS
PUBLIC HEALTH COMMUNINTY BASED SERVICES SERVICE SPECIFICATIONS Service Specification No: Service: Authority Lead: CBS18-19(03) Provision of intrauterine device (IUD), intrauterine system (IUS) and sub-dermal
More informationPower Point Use in EBPs. CAPP & PREP Learning Community May 15, 2018
Power Point Use in EBPs CAPP & PREP Learning Community May 15, 2018 Objectives Best practices for power point use Why use power point for EBP delivery Examples: the Good, the Bad and the Ugly Recommendations
More informationContraception and gynecological pathologies
1 Contraception and gynecological pathologies 18 years old, 2 CMI normal First menstruation at 14 years old Irregular (every 2/3 months), painful + She does not need contraception She is worried about
More informationCLINICAL PEARLS IN CONTRACEPTION
CLINICAL PEARLS IN CONTRACEPTION Laura Borgelt, PharmD, FCCP, BCPS Associate Professor University of Colorado Denver PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as
More informationContraceptive Updates and Recommendations
Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,
More informationContraceptive Updates and Recommendations
Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,
More informationPercentage of family planning clinics, according to clinic characteristics, by service focus, Title X funding status and clinic type, 2010 and 2015
TABLE 1 Percentage of family planning, according to clinic characteristics, by service focus, Title X funding status and clinic type, 2010 and Clinic characteristics 2010 Yes No Focuses on reproductive
More informationCONTRACEPTION OLD FRIENDS, NEW TRENDS
CONTRACEPTION OLD FRIENDS, NEW TRENDS AAP RECOMMENDATIONS 2014 1. Council about and ensure access to all contraceptive methods safe and appropriate describing most effective first. PEDIATRICS 134 (4)
More informationInstructions how to use the ESC teach the teachers course and self-learning tool
Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Female Sterilisation Prior Approval Policy Date Adopted: 6 th February 2017 Version: 1617.1 Individual Funding Request Team - A partnership between Bristol,
More informationEffective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO
Effective Contraception Utilization Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO Disclosures Contract Medical Director, EOCCO Objectives Illustrate how to best address contraception
More informationContraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014
Contraception Tami Allen, RNC OB, MHA Robin Petersen, RN, MSN Perinatal Clinical Nurse Specialist Objectives Discuss the impact of unintended pregnancy in the United States Discuss the risks and benefits
More informationHIV/Sexual Health Clinical Education Session
HIV/Sexual Health Clinical Education Session http://courses.ashm.org.au/hiv/hiv-sexual-health-clinical-education-session/ About These Slide These slides may not be published, posted online, or used in
More informationCODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40
CODING GUIDELINES FOR CONTRACEPTIVES Effective June 1, 2017 Version 1.40 TABLE OF CONTENTS ICD-10 CM Diagnosis Codes: Encounter for Contraception page 2 Coding for IUD Insertion and Removal Procedures
More informationPATIENT GROUP DIRECTION SUPPLY of Emergency Hormonal Contraception To females under 25 years Levonelle 1500 (Levonorgestrel 1500 micrograms)
PATIENT GROUP DIRECTION SUPPLY of Emergency Hormonal Contraception To females under 25 years Levonelle 1500 (Levonorgestrel 1500 micrograms) VALID FROM: 1 st July 2016 REVIEWED DATE: 30 th June 2019 This
More informationU.S. Medical Eligibility Criteria for Contraceptive Use, 2010
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 Division of Reproductive Health Centers for Disease Control and Prevention August 1, 2013 National Center for Chronic Disease Prevention and
More informationArdhanu Kusumanto Oktober Contraception methods for gyne cancer survivors
Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management
More informationLARC. sample. ask brook about. Are any of them right for me? How effective is it? How long does it last? long acting reversible contraception
72888_LARC:Layout 1 9/11/09 11:47 Page 1 Are any of them right for me? ask brook about LARC How effective is it? long acting reversible contraception How long does it last? 72888_LARC:Layout 1 9/11/09
More informationContraception in Medically Complicated Women
UCSF Essentials of Primary Care August 7, 2015 Squaw Creek, CA Contraception in Medically Complicated Women Michael Policar, MD, MPH Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine policarm@obgyn.ucsf.edu
More information2
1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive
More information